Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. This appears to be a metadata/version update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-12T20:43:37.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:38:46.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, and this update appears to be a version change that does not affect study data or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:09:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new 'Show glossary' option is now available and the footer displays 'Revision: v3.4.0'. The study dates section adds 'Last Update Submitted that Met QC Criteria' and capitalization for No FEAR Act items was adjusted.
    Difference
    0.2%
    Check dated 2026-01-28T16:56:42.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page shows a minor version update: Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:51:28.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added a new Locations section listing Tennessee (Nashville, Vanderbilt-Ingram Cancer Center) as a study site. Removed the separate Tennessee Locations entry in the footer.
    Difference
    0.2%
    Check dated 2025-12-23T21:24:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.